Proefschriften
Hieronder treft u een overzicht van de proefschriften vanaf 2008. Van alle proefschriften is een digitale samenvatting beschikbaar die u kunt bekijken en/of downloaden.
Voor informatie over de mogelijkheden rondom proefschriftsponsoring klikt u hier.
Optimising colorectal cancer surveillance in inflammatory bowel disease
A.M. Wijnands
08/11/2024
Utrecht
Applications and outcomes of gluteal flaps following rectal cancer surgery
S.I. Kreisel
25/10/2024
Amsterdam
Thioguanine in IBD: finding hidden treasures in old drugs
M. Simsek
02/10/2024
Amsterdam
Therapeutic Drug Monitoring in Inflammatory Bowel Disease: Establishes Drugs Revisited
M.M. van de Meeberg
01/10/2024
Amsterdam
Treatment management and health-related quality of life in autoimmune hepatitis
R.J.A.L.M. Snijders
24/09/2024
Nijmegen
Tailoring biological dosing and managing extra-intestinal manifestations in inflammatory bowel disease
F.M. Jansen
23/09/2024
Nijmegen
(Pre)malignant lesions of the biliary tree - beyond conventional endoscopic management
J.A. Fritzsche
20/09/2024
Amsterdam
Exploring professional and public perspectives on strategies for early detection of esophageal cancer
J. Sijben
20/06/2024
Nijmegen
Early Detection of Pancreatic Cancer in High-Risk Individuals
D.C.F. Klatte
04/06/2024
Leiden
Detection and Endoscopic Treatment of Esophageal Neoplasia
L. van Tilburg
29/05/2024
Rotterdam
Detection and molecular analysis of inflammation and malignancies in the gastro-intestinal tract.
R.Y. Gabriëls
29/05/2024
Groningen
Tailored surgery in ileocolic Crohn's disease - heading for gold
E.M. van der Does de Willebois
24/05/2024
Amsterdam
Molecular biomarkers to guide personalized treatment in colorectal cancer
S.J. Schraa
02/05/2024
Utrecht
Iron deficiency in inflammatory bowel disease: The underestimated adversary
R. Loveikyte
17/04/2024
Groningen
Towards early detection and durable treatment of chronic mesenteric ischemia
L.G. Terlouw
17/04/2024
Rotterdam
Early Detection of Pancreatic Cancer: the Juicy Details
I.J.M. Levink
12/04/2024
Rotterdam
Optimization and de-escalation of biologicals in patients with Crohn's disease
S. ten Bokkel Huinink
11/04/2024
Rotterdam
The Role of Food in Gastrointestinal Symptoms -The Influence of Various Food components and psychological factors
M.C.G. de Graaf
08/03/2024
Maastricht
Pharmaco-epigenetic biomarkers and optimization of post-operative management in inflammatory bowel disease
V.W. Joustra
14/02/2024
Amsterdam
The Dutch Pancreatic Cancer Project – towards improving nationwide outcomes and international standardization
S. Augustinus
26/01/2024
Amsterdam
Early detection of celiac disease: an exploration of clinical features and molecular biomarkers
I.L. Tan
22/01/2024
Groningen
No guts, no glory?! The physical and psychological consequences of pediatric intestinal failure
L.E. Vlug
20/12/2023
Rotterdam
Pancreatobiliary diseases - improving diagnosis and outcomes
N.C.M. van Huijgevoort
15/12/2023
Amsterdam
Assessing the surgical treatment of rectal carcinoma
T.A. Burghgraef
11/12/2023
Groningen
Towards optimal care in inflammatory bowel disease - thiopurines, tofacitinib and impact on working life
S. van Gennep
07/12/2023
Amsterdam
Features of esophageal cancer in the neoadjuvant setting
M.J. Valkema
29/11/2023
Rotterdam
Familial adenomatous polyposis: towards personalized care
A.S. Aelvoet
24/11/2023
Amsterdam
Optimizing immunomodulator and anti-TNF treatment in Inflammatory Bowel Diseases
E.H.J. Savelkoul
21/11/2023
Nijmegen
Advanced imaging and artificial intelligence for upper gastrointestinal endoscopy
K.N. Fockens
08/11/2023
Amsterdam
From bycatch to target: pathogenesis and clinical implications of the serrated pathway to colorectal cancer
D.E.F.W.M. van Toledo
03/11/2023
Amsterdam
Bacterial contamination of complex flexible gastrointestinal endoscopes
A.W. Rauwers
27/10/2023
Rotterdam
Alternatives in the Management of Inflammatory Bowel Diseases
A.G. Volkers
19/10/2023
Amsterdam
Duodenoscope Contamination and Duodenoscope-Associated Infections
J.A. Kwakman
10/10/2023
Rotterdam
Management of Inflammatory Bowel Disease – A long-term perspective
R. Mahmoud
28/09/2023
Utrecht
Minimal invasive strategies and quality improvement in colorectal cancer care
J.F. Huisman
19/09/2023
Utrecht
Prevention, early diagnosis and treatment of complications after colorectal surgery
K. Talboom
15/09/2023
Amsterdam
Fecal microbiota transplantation and dietary interventions in Inflammatory Bowel Disease; efficacy and challenges for the future
E. van Lingen
12/09/2023
Leiden
Pharmacologic treatment of Inflammatory Bowel Disease – Real world outcomes and optimizing strategies
T.S. Straatmijer
06/09/2023
Amsterdam
Innovations in surgical therapy for ulcerative colitis: the roaring twenties
M.A. Reijntjes
07/07/2023
Amsterdam
Unravelling the microbiome in Paediatric Crohn's Disease: a journey towards personalised therapy
C.M. Verburgt
16/06/2023
Amsterdam
Inflammatory Bowel Disease in Older Patients: from gut feeling towards evidence-based medicine
V.E.R. Asscher
06/06/2023
Leiden
Improving efficiency in the surgical treatment of acute appendicitis
E.M.L. de Wijkerslooth
06/06/2023
Rotterdam
Fluorescence Angiography in Gastrointestinal Surgery: The journey towards quantifying tisue perfusion
J.J. Joosten
02/06/2023
Amsterdam
Quantitative fluorescence molecular endoscopy: A multidimensional approach for cancer detection
I. Schmidt
31/05/2023
Groningen
Optimization of Biological Therapies in Patients with Inflammatory Bowel Disease: An analysis of prediction and monitoring strategies
R.W.M. Pauwels
24/05/2023
Rotterdam
ROMIC: studies on the role of ovarian metastases in colorectal cancer
R. van der Meer
11/05/2023
Maastricht
Early Detection of Esophageal Adenocarcinoma and its Precursor Barrett's Esophagus
Y. Peters
11/05/2023
Nijmegen
Surgical strategies in ulcerative colitis - New perspectives
L. Heuthorst
21/04/2023
Amsterdam
The first blow is half the battle - Treatment optimisation for peadiatric Inflammatory Bowel Disease patients
M.M.E. Jongsma
19/04/2023
Rotterdam
Pediatric Functional Abdominal Pain Disorders; From diagnosis to management - a clinical approach
R. Rexwinkel
14/04/2023
Amsterdam
Advanced Neoplasia in Inflammatory Bowel Diease: Prediction, Surveillance and Management
M. te Groen
04/04/2023
Nijmegen
Innovations in diagnosis and management of pancreatobiliary diseases
M. Gorris
31/03/2023
Amsterdam
Optimizing endoscopic therapy for early esophageal neoplasia
A. Overwater
30/03/2023
Utrecht
Design of a Synthetic Long Peptide Based Therapeutic Vaccine Strategy to Treat Chronic Hepatitis B
Y. Dou
22/03/2023
Rotterdam
Eosinophilic Esophagitis - New insights into an emerging disease
W.E. de Rooij
10/02/2023
Amsterdam
Improving the management of colorectal neoplasms in clinical practice
L.W. Leicher
02/02/2023
Leiden
Biomarker signatures in pathophysiology and therapeutic interventions in inflammatory bowel diseases - A multimodal approach
A.R. Bourgonje
01/02/2023
Groningen
The Dutch Pancreatic Cancer Project - Improving outcome in pancreatic surgery
J.A. Suurmeijer
27/01/2023
Amsterdam
Pediatric feeding problems and disorders - Psychosocial associations, tube feeding and tube weaning
H. Krom
20/01/2023
Amsterdam
Towards patient tailored management for Barrett’s related neoplasia
E.A. Nieuwenhuis
09/12/2022
Amsterdam
Esophageal cancer - Optimization of treatment strategies
B.M. Eyck
06/12/2022
Rotterdam
The gastroinstestinal tract - From healthy mucosa to colorectal cancer
F.E.R. Vuik
02/12/2022
Rotterdam
Molecular characterization and prediction to assess outcomes in Barrett’s esophagus and esophageal cancer
S.J.M. Hoefnagel
01/12/2022
Amsterdam
No more hide & seek - Strategies to optimize diagnosis and endoscopic treatment of complex colorectal neoplasms
R.M.M. Bogie
30/11/2022
Maastricht
Let’s be adaptable – Tissue T cell adaption in homeostasis and inflammation
L. Lutter
29/11/2022
Utrecht
Optimizing care in inflammatory bowel disease from the patient perspective
L.W. van Erp
17/11/2022
Nijmegen
Understanding the patient perspective for treatment outcomes and preferences in functional bowel disorders
R. Sturkenboom
09/11/2022
Maastricht
Fungal Feelings - The gut mycobiome in Irritable Bowel Syndrome and Inflammatory Bowel Disease
I.A.M. van Thiel
04/11/2022
Amsterdam
Novel diagnostic methods and treatment for Barrett’s Esophagus
A.C. Pacheco Correia
03/11/2022
Amsterdam
Optimal Staging and Surgical Treatment for Gastric Cancer
E.C. Gertsen
01/11/2022
Utrecht
Cross-talk between microbiota and immune responses in inflammatory bowel disease
S. Rahman
28/10/2022
Amsterdam
Optimizing endoscopic treatment for complex colorectal polyps and T1 cancer
L.W. Zwager
21/10/2022
Amsterdam
Left is right: the effect of sleep position on nocturnal gastroesophageal reflux
J.M. Schuitenmaker
17/10/2022
Amsterdam
Optimizing medical treatment of inflammatory bowel disease - Towards value-based and personalized therapy
L.J.T. Smits
14/10/2022
Nijmegen
Patient-reported outcomes, drug safety and biological therapies in Inflammatory Bowel Disease
P.A.W. Thomas
13/10/2022
Nijmegen
Quality measurement and assessment in gastrointestinal endoscopy
K.J. Nass
12/10/2022
Amsterdam
Human-machine collaboration: improving endoscopic detection and characterization of colorectal neoplasia
B.B.S.L. Houwen
30/09/2022
Amsterdam
Laparoscopic versus open gastrectomy for gastric cancer
A. van der Veen
22/09/2022
Utrecht
Point-of-care ultrasonography for the monitoring of inflammatory bowel disease
F.A.E. de Voogd
21/09/2022
Amsterdam
It doesn't end with closure - Optimizing health care throughout life after esophageal atresia repair
C.A. ten Kate
14/09/2022
Rotterdam
Postoperative recurrence of Crohn's disease after ileocolonic resection - Epidemiology, prediction and prevention
E.M.J. Beelen
29/06/2022
Rotterdam
Recent advances in genetic iron overload-related disorders - With special focus on ferritin and HFE-related hemochromatosis
W. Moris
29/06/2022
Maastricht
Screening and Surveillance of the Gastrointestinal Tract
S.A.V. Nieuwenburg
24/06/2022
Rotterdam
Disorders of continence and defaecation – Insights into risk factors, underlying pathophysiology and treatment
P.F. Vollebregt
24/06/2022
Amsterdam
Esophageal neoplasia revisited - Risk stratification, treatment, and long-term outcomes
S.N. van Munster
17/06/2022
Amsterdam
The role of the Dutch dietary and physical activity guidelines in Inflammatory Bowel Disease – Implications for clinical practice
C.R. Lamers
08/06/2022
Wageningen
Tailor-made treatment of patients with multiple endocrine neoplasia type 1-related duodenopancreatic neuroendocrine tumors
D.J. van Beek
02/06/2022
Utrecht
Optimizing performance and techniques in advanced pancreatobiliary endoscopy
S.E. van der Wiel
31/05/2022
Rotterdam
Gut-liver interactions in primary sclerosing cholangitis and inflammatory bowel disease
M. de Krijger
13/05/2022
Amsterdam
Organ-specific interventions in intestinal transplantation
G. Trentadue
11/05/2022
Groningen
Metabolic associated fatty liver disease - Prevalence and determinants
E.H. Wouters-van den Berg
20/04/2022
Groningen
Prevention of symptomatic gallstone disease after bariatic surgery
S. Haal
08/04/2022
Amsterdam
Towards improved risk stratification in Barrett’s esophagus
E. Klaver
30/03/2022
Amsterdam
Multidisciplinary management of severe acute pancreatitis
L. Boxhoorn
25/03/2022
Amsterdam
Staging and surgical treatment of gastric cancer - Surgery during the COVID-19 pandemic
A.B.J. Borgstein
18/03/2022
Amsterdam
Non-invasive monitoring & treatment strategies – In paediatric Inflammatory Bowel Disease
E.A. van Wassenaar
18/03/2022
Amsterdam
Moving Forward - New insights into esophageal motility disorders
R.A.B. Oude Nijhuis
03/02/2022
Amsterdam
Serrated polyposis syndrome - A multidisciplinary approach
Y.J. van Herwaarden
20/01/2022
Nijmegen
Locally advanced pancreatic cancer – Exploring treatment strategies
M.S. Walma
13/01/2022
Utrecht
Circulating biomarkers in pancreatic cancer patients treated with FOLFIRINOX - To treat or not to treat?
F. van der Sijde
08/12/2021
Rotterdam
Epigenetic morphology and classification of neuroendocrine turmors
W.M. Hackeng
02/12/2021
Utrecht
Pregnancy and inflammatory bowel disease - Perspectives from bench and bedside
J. van der Giessen
17/11/2021
Rotterdam
Treatment allocation and evolving surgical strategies in gastroesophageal cancer
M.C. Kalff
05/11/2021
Amsterdam
Autophagy and Crohn's disease - Opportunities in personalised medicine
M.M.C. Prins
05/11/2021
Amsterdam
Investigating new biomarkers and therapy options in oesophagogastric cancer
W.J. Koemans
03/11/2021
Amsterdam
Unravelling disease activity in IBD; a key to personalized medicine - Epidemiological patterns, modifiable risk factors, and treatment implications
D. Wintjens
22/10/2021
Maastricht
Endoscopische duodenale mucosale ablatie ter behandeling van diabetes mellitus type 2
A.C.G. van Baar
15/10/2021
Amsterdam
Irritable Bowel Syndrome - From Diagnostic Criteria to Targeted Treatment
Z.Z.R.M. Weerts
15/10/2021
Maastricht
Diagnosis and treatment of early esophageal carcinoma and second primary tumors in the upper aero digestive tract
S.E.M. van de Ven
13/10/2021
Rotterdam
Gut mucosal gene expression in inflammatory bowel disease - The heterogeneous nature of inflammation
W.T.C. Uniken Venema
29/09/2021
Groningen
Catching wind of non-invasive biomarkers for inflammatory bowel disease and colorectal cancer
S. Bosch
20/09/2021
Amsterdam
Intestinal Wound Healing – Modulation by Enteric and Mesenteric Factors
J.H.M. van der Meer
17/09/2021
Amsterdam
Novel strategies to address disrupted sensing and signalling of satiety
T. Klaassen
03/09/2021
Maastricht
Tailoring diagnosis and treatment of symptomatic cholecystolithiasis
C. Latenstein
01/07/2021
Nijmegen
The nature of gut microbiota in early life - Origin and impact of pioneer species
N. van Best
30/04/2021
Maastricht
Nutrition and disease course in Inflammatory Bowel Disease
C.E.G.M. Spooren
29/04/2021
Maastricht
A critical evaluation of diagnostic tools in abdominal surgery
V.P. Bastiaenen
16/04/2021
Amsterdam
MEASuRing symptoms in lrritable Bowel Syndrome - Towards an lndividualized and Daily Life approach
L. Vork
09/04/2021
Maastricht
Advanced imaging techniques for detection of Barrett’s neoplasia
M.R. Struyvenberg
19/03/2021
Amsterdam
Treatment of obstructive colon cancer - A shifting paradigm
J.V. Veld
11/03/2021
Amsterdam
Evaluation and improvement of nationwide practice in pancreatic and periampullary cancer
A. Latenstein
05/03/2021
Amsterdam
The exposome in development and behaviour of inflammatory bowel disease
K.W.J. van der Sloot
03/03/2021
Groningen
Inflammatory Bowel Disease Therapies - From efficacy to effectiveness
V.B.C. Biemans
26/02/2021
Nijmegen
Towards treatment of liver fibrosis; cells, targets and models
D. van der Helm
11/02/2021
Leiden
Research in surgical treatment of inflammatory bowel disease - Rethinking dogmas
K.A.T.G.M. Wasmann
29/01/2021
Amsterdam
Safety and efficacy of Inflammatory Bowel Disease Treatment - A challenging balance
J.E. Kreijne
27/01/2021
Rotterdam
Gut maturation: from in vitro to in vivo models, and the role of early life nutrition
M. Navis
15/01/2021
Amsterdam
MRI for personalised treatment in oesophageal cancer
S.E. Vollenbrock
09/12/2020
Maastricht
Connecting the dots - A multidisciplinary approach to optimize rectal cancer treatment outcomes
S. Hoendervangers
19/11/2020
Utrecht
New strategies for endoscopic recognition of Barrett neoplasia
A.J. de Groof
18/11/2020
Amsterdam
Janus kinase inhibition in the treatment of Inflammatory Bowel Disease
L.C.S. de Vries
11/11/2020
Amsterdam
Treatment strategies for strictures and perforations of the esophagus
B.D. Vermeulen
04/11/2020
Nijmegen
The Serrated neoplasia pathway to colorectal cancer - Molecular biology and clinical management
A. Bleijenberg
28/10/2020
Amsterdam
Long-term follow-up after esophageal atresia repair - Gastrointestinal morbidity in children and adults
F.W.T. Vergouwe
28/10/2020
Rotterdam
Carcinogenesis, prediction and palliative treatment of gastrointestinal cancer
V.T. Janmaat
27/10/2020
Rotterdam
Implications of Postoperative Ileus - From experimental to clinical studies
E.G. Peters
26/10/2020
Amsterdam
Paediatric functional gastrointestinal disorders - Prevalence, patient reported outcomes and guideline implementation
N.F. Steutel
22/10/2020
Amsterdam
Esophageal cancer treatment - Predicting and improving short- and long-term outcomes
E.R.C. Hagens
09/10/2020
Amsterdam
Unravelling functional abdominal pain disorders from infancy to adolescence - Insights into epidemiology, diagnostics and treatment
J. Zeevenhooven
02/10/2020
Amsterdam
Clinicopathological outcome and prognostication in pancreatic surgery
S. van Roessel
02/10/2020
Amsterdam
Role of nutritional interventions and aging in intestinal health
E. Wilms
24/09/2020
Maastricht
Surgery in Inflammatory Bowel Disease - A different point of view
M. Stellingwerf
18/09/2020
Amsterdam
Maintenance and disruption of intestinal epithelial homeostasis
B.J. Meijer
25/08/2020
Amsterdam
Stromal cells in Inflammatory Bowel Disease - Perspectives of local mesenchymal stromal cell therapy
M.C. Barnhoorn
03/07/2020
Leiden
Macrophages as a therapeutic target in IBD lessons learned from anti-TNF therapy
F.M. Bloemendaal
03/07/2020
Amsterdam
The Dutch Pancreatic Cancer Project - Tools for a tailored approach to pancreatic and periampullary cancer treatment
M. Strijker
26/06/2020
Amsterdam
Quality of life in Inflammatory Bowel Disease - When IBD goes beyond the gut
N.Z. Borren
17/03/2020
Rotterdam
Using the mouse to study Barrett’s Esophagus - We ain’t that different after all
D. Straub
12/02/2020
Amsterdam
Chronic mesenteric ischemia in the picture - New diagnostic techniques and treatment modalities
L.J.D. van Dijk
21/01/2020
Rotterdam
Locally advanced colon cancer and peritoneal metastases - From biological pathway to treatment strategies
C.E.L. Klaver
16/01/2020
Amsterdam
FIT for Colorectcal Cancer Screening – From standard to tailored strategies
E. Wieten
18/12/2019
Rotterdam
What makes an Expert Barrett’s pathologist? Concordance and pathologist expertise within a digital review panel
M.J. van der Wel
11/12/2019
Amsterdam
Temporal changes in the epidemiology, treatment and outcome of inflammatory bowel disease in South Limburg
S. Jeuring
10/12/2019
Maastricht
Esophageal Cancer: Prognostication and Individualized Treatment
E. Visser
28/11/2019
Utrecht
Personalized treatment with anti-TNF agents in Inflammatory Bowel Disease
A.S. Strik
27/11/2019
Amsterdam
Genetic Susceptibility for Inflammatory Bowel Disease across ethnicities and diseases
S. van Sommeren
25/11/2019
Groningen
Optimizing EUS-guided tissue sampling: novel devices and techniques
P.A. van Riet
20/11/2019
Rotterdam
Fecal incontinence, risk factors, impact on quality of life, and future treatment strategies
A.P. Visscher
08/11/2019
Amsterdam
A Dynamic Balance: Regulatory and inflammatory T-cell reponse
M.E. Joosse
06/11/2019
Rotterdam
Implementation phase of the Dutch colorectal cancer screening programme
E. Toes-Zoutendijk
01/11/2019
Rotterdam
Optimizing Care for Children with Intestinal Failure: the gut and beyond
E.G. Neelis
30/10/2019
Rotterdam
Early detection of colorectal cancer: towards better surveillance
Meta C.J. van Lanschot
29/10/2019
Utrecht
Dysplasia in IBD: towards an improved risk stratification
J.R. ten Hove
29/10/2019
Utrecht
Biological and Clinical Parameters to Improve Outcome in Oesophageal Cancer
E.L.A. Toxopeüs
02/10/2019
Rotterdam
Diagnostic modalities and outcome measures in upper gastrointestinal disorders
F.G.M. Smeets
27/09/2019
Maastricht
To boost or not to boost; the role of radiotherapy on the quality of life in patients with rectal cancer
A.M. Couwenberg
26/09/2019
Utrecht
Optimization of endoscopic treatment for Barrett’s esophagus with early neoplasia
K. Belghazi
11/09/2019
Amsterdam
Biomarkers, Models and Mechanisms of Intestinal Fibrosis
W.T. van Haaften
11/09/2019
Groningen
A Translational Approach Towards Perihilar Cholangiocarcinoma
E. Roos
14/06/2019
Amsterdam
The PROMise of remote monitoring to improve quality of care for inflammatory bowel disease
M.J. de Jong
14/06/2019
Maastricht
Complications and salvage surgery following restorative and non-restorative rectal cancer resection
E. Westerduin
10/05/2019
Amsterdam
Expanding eligibility and improving patient outcomes for pancreatic cancer surgery
S. Klompmaker
26/04/2019
Amsterdam
Optimizing colorectal cancer screening using fecal immunochemical tests
C.M. de Klerk
18/04/2019
Amsterdam
The Dutch Pancreatic Cancer Project: Optimization of Clinical Research in Pancreatic Cancer
L.B. van Rijssen
05/02/2019
Amsterdam
Minimally invasive pancreatic resection: introduction, development, and outcome assessment
J. van Hilst
01/02/2019
Amsterdam
Surveillance of adenoma patients – towards more efficient guidelines
E.M.B. van Heijningen
19/12/2018
Rotterdam
Improving the quality of colonoscopy, detection and resection of colorectal polyps
M.E.S. Bronzwaer
12/12/2018
Amsterdam
IBD THERAPY REDESIGNED - From established therapeutic regimens to prospective epigenetic approaches
N.W. Duijvis
05/12/2018
Amsterdam
Clinical and genetic factors associated with disease course in inflammatory bowel disease
L.M. Spekhorst
14/11/2018
Groningen
Profiling the immune response in early inflammatory bowel disease
C. Smids
02/11/2018
Nijmegen
Optimizing peri-operative care in bariatric surgery patients
U. Coblijn
18/10/2018
Amsterdam
The unfolded protein responde in intestinal stem cells – a focus on cancer
J. van Lidth de Jeude
12/10/2018
Amsterdam
Lynch syndrome – Improving diagnostics and surveillance
A. Goverde
26/09/2018
Rotterdam
A multimodality approach to improve oesophageal and gastric cancer treatment
R. van der Kaaij
21/09/2018
Amsterdam
Towards minimal invasive treatment of T1 colorectal cancer
Y. Backes
20/09/2018
Utrecht
Nutrient Sensing in the gut. Appetite regulation in health and obesity.
M. van Avesaat
05/07/2018
Maastricht
Reducing pulmonary complications after esophagectomy for cancer
M.F.J. Seesing
04/07/2018
Utrecht
Fibrosis and vitamin D in inflammatory bowel disease; IBD considered from both basic and clinical perspectives
J.R. de Bruyn
29/06/2018
Amsterdam
Optimization of treatment strategies and prognostication for patients with esophageal cancer
M.C.J. Anderegg
28/06/2018
Amsterdam
Advanced endoscopic imaging for detection and differentiation of colorectal neoplasia
J.L.A. Vleugels
27/06/2018
Amsterdam
Optimizing the step-up approach for infected necrotizing pancreatitis
J. van Grinsven
22/06/2018
Amsterdam
Epigenetic mechanisms regulating the inflammatory response
R. Schilderink
25/05/2018
Amsterdam
Optimization of treatment with conventional thiopurines in inflammatory bowel disease
M.T.J. Broekman
15/05/2018
Nijmegen
Pediatric Inflammatory Bowel Disease: monitorin, nutrition and surgery
K. Diederen
04/05/2018
Amsterdam
Functional defecation disorders in children - novel insights into epidemiology, evaluation and management
I.J.N. Koppen
06/04/2018
Amsterdam
Endoscopy in the upper gastrointestinal tract - new devices and existing techniques
W.F.W. Kappelle
27/03/2018
Utrecht
Pediatric gastroesophageal motility disorders – diagnostic possibilities and pitfalls
M.M.J. Singendonk
16/03/2018
Amsterdam
Acute Necrotizing Pancreatitis – Improving outcome
S. van Brunschot
16/03/2018
Amsterdam
Colon cancer - the clinical significance of molecular biomarkers
R.R.J. Coebergh van den Braak
31/01/2018
Rotterdam
Optimizing endoscopic therapy for early Barrett's neoplasia
H.T. Künzli
26/01/2018
Amsterdam
Mechanism of action of anti-TNF therapy in Inflammatory bowel disease - towards improving efficacy of anti-TNF therapy
A.D. Levin
19/01/2018
Amsterdam
Developments in the management of esophageal dysfunction
F.B. van Hoeij
12/01/2018
Amsterdam
Epidemiology of microscopic colitis: exploring leads for pathophysiological mechanisms
B.P.M. Verhaegh
10/01/2018
Maastricht
The impact of low skeletal muscle mass in abdominal surgery
J.L.A. van Vugt
20/12/2017
Rotterdam
Pathogenesis and prevention of gastrointestinal neoplasia in Hodgkin lymphoma survivors
L. Rigter
13/12/2017
Amsterdam
Clinical evaluation of the endoscopic duodenal-Jejunal Bypass liner for the managament of type 2 diabetes and obesity
P. Koehestanie
12/12/2017
Nijmegen
The epidemiology of inflammatory bowel disease in South Limburg
T.R.A. van den Heuvel
12/12/2017
Maastricht
The intestinal microbiota disrupted & restored - On Clostridium difficile infection and fecal donation
Y.H. van Beurden
08/11/2017
Amsterdam
Solid benign liver tumours - Biological behaviour and management
M.E.E. Bröker
01/11/2017
Rotterdam
Fluorescence-guided cancer surgery using clinical available and innovative tumor-specific contrast agents
Q.R.J.G. Tummers
11/10/2017
Leiden
Towards better understanding of symptoms associated with disordered esophageal function
T.V.K. Herregods
10/10/2017
Amsterdam
Biocompatibility of new and existing biomaterials for abdominal wall surgery
R.R.M. Vogels
06/10/2017
Maastricht
The gut in control of health and disease: Unraveling the role of short-chain fatty acids in human metabolism”
C.M. van der Beek
04/10/2017
Maastricht
Surgical strategies in MEN1 related pancreatic neuroendocrine tumours
S. Nell
29/09/2017
Utrecht
Advances in approach and therapy for early esophageal neoplasia
D.W. Schölvinck
27/09/2017
Amsterdam
Hereditary & Familial Colorectal Cancer - identification, characteristics, surveillance
F. Kallenberg
08/09/2017
Amsterdam
Visualizing and targeting oxidative stress in hepatic ischemia-reperfusion injury
M.J. Reiniers
05/07/2017
Amsterdam
Hepatitis C: Generalization of Trials to Clinical Practice
F.A.C. Berden
30/06/2017
Nijmegen
A treatment rationale for surgery-induced liver injury
R.F. van Golen
28/06/2017
Amsterdam
The spectrum of gluten related diseases - diagnosis, epidemiology and treatment
P. Nijeboer
20/06/2017
Amsterdam
Current and advanced knowledge on ADMA and the glutamine-citrulline-arginine-pathway in surgery and critical illness”
S.J.H. Brinkmann
08/06/2017
Amsterdam
Societal and economic aspects of inflammatory bowel disease
M. Severs
08/06/2017
Utrecht
Advances in locally advanced pancreatic cancer treatment
S.J.E. Rombouts
08/06/2017
Utrecht
New concept in ulcerative colitis: a thin line between medicine and surgery
S. Sahami
02/06/2017
Amsterdam
Surgery and medical therapy in Crohn's disease - improving treatment strategies
E.J. de Groof
02/06/2017
Amsterdam
Volumetric laser endomicroscopy for the detection of early Barrett's neoplasia
A. Swager
02/06/2017
Amsterdam
Advances in Barrett's esophagus surveillance and improved prediction of prognosis and therapy response in patients with esophageal adenocarcinoma
S. van Olphen
24/05/2017
Rotterdam
A blueprint for multidisciplinary fast track gastrointestinal oncology care
Y.L. Basta
28/04/2017
Amsterdam
Progress toward less invasive diagnosis and better recognition of disease activity and complications of celiac disease
M.P.M. Adriaanse
21/04/2017
Maastricht
Colorectal Anastomotic Leakage - A call for a different approach
J.W.A.M. Bosmans
31/03/2017
Maastricht
Chronic Pancreatitis: novel concepts in diagnostics and treatment
Y. Issa
31/03/2017
Amsterdam
New approaches to the surgical treatment of intra-abdominal infection
I.M. Mulder
29/03/2017
Rotterdam
Nutritional interventions focusing on gastrointestinal and metabolic health
B. Salden
17/03/2017
Endoscopic detection adn treatment of colorectal polyps
T.D.G. Belderbos
09/03/2017
Utrecht
Targeting stromal interactions in the pro-metastatic tumor microenvironment - Endoglin & TGF-β as (un)usual suspects
M. Paauwe
09/02/2017
Leiden
Nutrition and amino acid metabolism in critically ill patients
M.A.R. Vermeulen
03/02/2017
Amsterdam
Adenocarcinoma of the gastroesophageal junction: challenges in staging and treatment
K. Parry
02/02/2017
Utrecht
Serrated polyps-carcinogenesis and clinical implications
J.E.G. Ijspeert
27/01/2017
Amsterdam
Early detection and pathogenesis during the progression of Barrett's esophagus to esophageal adenocarcinoma
C. Kestens
19/01/2017
Utrecht
Solid intra- and extra-intestinal malignancies in inflammatory bowel disease
L.A.A.P. Derikx
17/01/2017
Nijmegen
Improvement of diagnosis and treatment of pancreatic diseases
S.J. Lekkerkerker
11/01/2017
Amsterdam
Risk assessment and perioperative care in perihilar cholangiocarcinoma
R.J. Coelen
23/12/2016
Optimizing colorectal cancer screening- new strategies and insights
E. Schreuders
15/12/2016
Biomarkers for disease progression in primary sclerosing cholangitis
L. de Vries
18/11/2016
Biomarkers in premalignant conditions of the gastrointestinal tract- Studies on Barrett's Esophagus and Primary Sclerosing Cholangitis
M.R. Timmer
10/11/2016
Helicobacter pylori- epidemiology, premalignant gastric lesiona, and associations with non-gastric disease
W.J. den Hollander
14/09/2016
Advances in colonoscopic imaging and approach to dysplasia in IBD
L.K. Wanders
01/07/2016
Effects of Non-Steroidal Anti-Inflammatory drugs on the Gastrointestinal and Cardiovascular System
G.M.C. Masclee
29/06/2016
Towards Personalized Medicine in Treatment and care of Patients with Peritoneal Metastases of Colorectal Cancer
E.M.V. de Cuba
09/06/2016
Management of early neoplasms and surgical complications of the rectum
G.D. Musters
06/04/2016
Implications for future management of IBD, lessons from cohort studies
V.J.A.A. Nuij
29/03/2016
Mesenchymal stromal cell therapy for Crohn's disease from perianal fistulizing disease to experimental colitis
I. Molendijk
15/03/2016
Minimally invasive strategies for the surgical treatment of colonic peritonitis
S. Vennix
19/02/2016
The microbiome and its therapeutic potential in inflammatory bowel diseases
N.G.M. Rossen
22/01/2016
Reflux perception and the esophageal mucosal barrier in gastroesophageal reflux disease
P.W. Weijenborg
19/01/2016
Virus-host interplay in chronic Hepatitis B: Predicting response to immunomodulating antiviral therapy
L. Jansen
15/01/2016
Combating (pre)malignant Pancreatic Disease: High Time for Molecular Markers
W.K. Utomo
22/12/2015
Irritable Bowel Syndrome: Pathophysiology, Symptoms and Biomarkers
Z. Mujagic
21/12/2015
Genetic aspects of chronic pancreatitis. From autosomal dominant disease to modifying genetic factors
M.H.M Derikx
21/12/2015
Autoimmune Pancreatitis- Novel insights on Diagnosis, Treatment and Outcome
J. Buijs
16/12/2015
QUEST for the BEST: Quality of colonoscopy and colorectal cancer diagnosis in clinical practice
C.M.C. le Clercq
11/12/2015
THIOPURINES- improving treatment of inflammatory bowel disease
D. van Asseldonk
04/12/2015
Improving the outcomes of esophagectomy: anatomic, surgical and postoperative aspects
T.J. Weijs
19/11/2015
Clinical, psychosocial and therapeutic aspects of Irritable Bowel Syndrome.-Results of cohort studies and a probiotic interventional trial-
A.Y. Thijssen
19/11/2015
Effects of bariatric surgery on gastroesophageal motor function
J.S. Burgerhart
12/11/2015
To keep a balance in disease specific intestinal insufficiency. Dianostics and practical nutritional aspect
N.J. Wierdsma
12/11/2015
Systematic mechanism-orientated approach to chronic pancreatitis pain
S.A.W. Bouwense
30/10/2015
Advances in Gastric and Gastro-Esophageal Juntion Surgery for Cancer
L. Haverkamp
06/10/2015
Complications in home parenteral nutrition patients: from lock solutions to lipids
E.D. Olthof
21/09/2015
Stents in the upper gastrointestinal tract: novel designs and indications
D. Walter
17/09/2015
Functional abdominal pain disorders in children - Therapeutic strategies focusing on hypnotherapy
J.M.T.M. Rutten
11/09/2015
Exploring fatigue in inflammatory bowel disease patients, associated factors and management
L. Vogelaar
02/09/2015
Homeostasis of the esophageal epithelium; A quest for the stem cell
S.L. Rosekrans
03/07/2015
Pediatric esophageal motility disorders, studies on (patho)physiology, diagnosis and management’
M.J. Smits
11/06/2015
Intestinal cell damage, inflammation and wound healing in major gastrointestinal surgery
K.W. Reisinger
05/06/2015
Image-Guided Cancer Surgery; The value of near-infared fluorescence imaging during oncologic and gastrointestinal procedures
F.P.R. Verbeek
03/06/2015
Prevention of colorectal cancer development and mortality: from epidemiology to endoscopy
V.K. Dik
28/05/2015
Towards molecular imaging for personalized therapy of patients with colorectal cancer liver metastasis
J.A.C.M. Goos
13/05/2015
Abdominal Wall Hernia Repair: Intraperitoneal Mesh and Adhesions
M.H.F. Schreinemacher
10/04/2015
Fecal microbiota transplantation, clinical and experimental studies
E. van Nood
01/04/2015
Colorectal cancer screening by means of repeated faecal immunochemical testing (FIT
A. Kapidzic
06/02/2015
Oesophagohastric cancer: exploring the way to an individual approach
J. Stiekema
22/01/2015
Evolving concepts of staging and treatment of colorectal cancer
D. Sloothaak
21/01/2015
The burden of inflammatory bowel disease from an individual and societal perspective
M. van der Have
08/01/2015
Endoscopic stent placement throughout the gastrointestinal tract
M.W. van den Berg
11/12/2014
Surveillance of individuals at high risk for developing pancreatic cancer
F. Harinck
04/12/2014
Prognostic significance of biomarker expression in esophageal adenocarcinoma
M. Prins
04/12/2014
Biomarkers for inflammation and surveillance strategies in inflammatory bowel disease
E. Mooiweer
02/12/2014
Exploring faecal immunochemical test performance for colorectal cancer screening
S. van Turenhout
26/11/2014
Inflammation in Ischemia and Reperfusion: from mice to men
G.M.P. Diepenhorst
18/11/2014
The intestinal barrier function: an integrative approach to understanding gastrointestinal pathophysiology
D. Keszthelyi
23/10/2014
Gene and environmental interactions in IBD- emphasis on smoking and autophagy
A. Regeling
08/10/2014
Biliary complications after liver transplantation: new insights and biomarkers
W.R.R. Farid
07/10/2014
Malignant progression of Barrett’s esophagus: pathogenesis, surveillance and follow-up
R. Verbeek
02/10/2014
Optimizing surveillance in Barrett's esophagus: from chemoprevention and biomarkers to cost-effectiveness and survival
F. Kastelein
10/09/2014
Competence and quality assessment – the future of training in GI endoscopy
V.E. Ekkelenkamp
05/09/2014
Endoscopic treatment of Obesity and Metabolic disorders, Basic and Clinical studies on the effect of the Duodenal-Jejunal Bypass Liner
C. de Jonge
05/09/2014
Clinical aspects of patients with irritable bowel syndrome, with a special focus on visceral hypersensitivity and intestinal permeability
S. Ludidi
03/09/2014
Novel approaches to upper gastrointestinal conditions: a focus on bleeding and malignancy
I.L. Holster
13/06/2014
Near-infrared fluorescence-guided surgery, Pre-clinical validation and clinical translation
J.R. van der Vorst
01/05/2014
Crohn's disease: mucosal immunology and immune modulating therapy
C.P. Peters
25/04/2014
Advances in imaging and endoscopic therapy in Barrett’s esophagus
Lorenza Alvarez Herrero
16/04/2014
Unraveling Childhood Constipation; pathophysiology, diagnostics and treatment
S.M. Mugie
11/04/2014
Shifting emphasis in pancreatic surgery – pre-, intra-, and postoperative determinants of outcome
W. Eshuis
11/04/2014
Pediatric Gastroesophageal reflux disease; current diagnoses and management
R. van der Pol
21/03/2014
Advanced imaging of oesophageal neoplasia; Old looks and new visions
D.F. Boerwinkel
12/03/2014
Gene and cell therapy based treatment strategies for inflammatory bowel diseases
S. van der Marel
18/02/2014
Screening modalities for colorectal cancer; Results from a workplace based cohort in the Netherlands
C.A.J. Khalid-de Bakker
12/02/2014
Immunoglobulin A-induced neutrophil migration: how the IgA Fc receptor FcaRI can aggravate tissue damage
L.P.E. van der Steen
06/02/2014
Ethanol and intestinal barrier: human intervention and mechanistic in vitro studies
E. Elamin
23/01/2014
The Genetics of Detoxification Enzymes and Esophageal Cancer Susceptibility
P. Dura
22/01/2014
